Analysis | Pfizer's RSV Vaccine Succeeds Where Others Failed
Briefly

As parents worry over the cases of RSV filling up pediatric hospitals in the US, finally some good news: Vaccines that protect newborns from the virus could be ready in time for next year's season.Pfizer Inc. today unveiled promising data on a maternal RSV shot that shows it lowered babies' risk of severe infections in those vulnerable first months of life.
Read at Washington Post
[
add
]
[
|
|
]